EGFR-Mutated Metastatic NSCLC: Evolving Practice Standards and Opportunities for Improving Outcomes

Gain global insights on the optimal care of patients with advanced EGFR-mutated NSCLC in this comprehensive online program including a Podcast and an on-demand Webcast of a CCO live Webinar both featuring medical oncologists from the United States and Europe along with expert-authored commentaries and a regularly updated downloadable slideset.

Share

Program Content

Activities

Adv <i>EGFR+</i> NSCLC in 2021
What Everyone Should Know About Management of Advanced EGFR-Mutated Non-Small-Cell Lung Cancer in 2021
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: March 08, 2021

Expires: March 07, 2022

Adv <i>EGFR</i>+ NSCLC: EU/US Perspectives
Regional Perspectives on Current Management of Advanced EGFR-Mutated Non-Small-Cell Lung Cancer
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: April 20, 2021

Expires: April 19, 2022

Liquid Biopsy in <i>EGFR+</i> NSCLC
My Thoughts on the Evolving Role of Liquid Biopsies in the Treatment of EGFR Mutation–Positive Advanced NSCLC
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: June 01, 2021

Expires: May 31, 2022

Barriers to Osimertinib
First-line Osimertinib for EGFR-Mutated Advanced NSCLC: Barriers to Access and Future Directions
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 29, 2021

Expires: July 28, 2022

Activities

<i>EGFR</i>+ Adv NSCLC
EGFR-Mutant Advanced NSCLC: Global Insights on Testing and Treatment Planning
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 23, 2021

Expires: June 22, 2022

<i>ExpressPoints: EGFR</i>+ Adv NSCLC
ExpressPoints: EGFR-Mutant Advanced NSCLC: Global Insights on Testing and Treatment Planning
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 23, 2021

Expires: June 22, 2022

Activities

<i>EGFR</i>m NSCLC: Global Insights
Improving Outcomes in EGFR-Mutated Non-Small-Cell Lung Cancer: Global Insights on Evolving Practice Standards
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: March 25, 2021

Expires: March 24, 2022

<i>EGFR</i>m NSCLC: Podcast Pearls
Improving Outcomes in EGFR-Mutated Non-Small-Cell Lung Cancer: Podcast Pearls
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: March 25, 2021

Expires: March 24, 2022

Activities

Global Insights on <i>EGFR</i>+ Adv NSCLC
EGFR-Mutant Advanced NSCLC: Global Insights on Testing and Treatment Planning
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: July 29, 2021

Expires: July 28, 2022

Faculty

cover img faculity

Enriqueta Felip, MD

Head, Thoracic Oncology Unit
Oncology Service
Vall d Hebron University Hospital
Barcelona, Spain

cover img faculity

Matthew Gubens, MD, MS

Associate Professor
Thoracic Oncology
University of California, San Francisco
San Francisco, California

cover img faculity

Edward S. Kim, MD

Chief, Section of Head and Neck Medical Oncology
Associate Professor, Thoracic/Head and Neck Medical Oncology
University of Texas M. D. Anderson Cancer Center
Houston, Texas

cover img faculity

Tetsuya Mitsudomi, MD

Professor
Department of Thoracic Surgery
Kindai University Faculty of Medicine
Osaka-Sayama, Japan

cover img faculity

Luis Paz-Ares, MD, PhD

Chair of the Medical Oncology Department
Hospital Universitario 12 de Octubre
Associate Professor
Universidad Complutense de Madrid
Head of the Lung Cancer Unit
CNIO (Spanish National Cancer Research Center)
Madrid, Spain

cover img faculity

David Planchard, MD, PhD

Head of Thoracic Cancer Group
Department of Medical Oncology
Gustave Roussy
Paris-Saclay University
International Center for Thoracic Cancers
Villejuif, France

cover img faculity

Christian Rolfo, MD, PhD, MBA, Dr.hc.

Professor of Medicine
Division of Hematology and Oncology
Icahn School of Medicine at Mount Sinai
Associate Director of Clinical Research
Center for Thoracic Oncology
The Tisch Cancer Institute
Mount Sinai Health System
New York, New York

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

AstraZeneca